A phase-II trial ofCorynebacterium parvu
โ
Michael Woodruff; Philip Walbaum
๐
Article
๐
1983
๐
Springer-Verlag
๐
English
โ 283 KB
A phase-II randomized trial has been undertaken in 49 patients with operable lung cancer, to determine the effect of a single IV infusion of killed C. parvum vaccine as an adjuvant to surgery. The number of patients was insufficient to provide a decisive result, but analysis 6 years after the last p